McKesson Stock Hits New 52-Week High (MCK)

NEW YORK ( TheStreet) -- McKesson (NYSE: MCK) hit a new 52-week high Tuesday as it is currently trading at $88.15, above its previous 52-week high of $88.02 with 360,192 shares traded as of 10:15 a.m. ET. Average volume has been 1.6 million shares over the past 30 days.

McKesson has a market cap of $18.8 billion and is part of the services sector and wholesale industry. Shares are up 12.4% year to date as of the close of trading on Monday.

McKesson Corporation delivers medicines, pharmaceutical supplies, information, and care management products and services for the healthcare industry. The company has a P/E ratio of 20.1, above the average wholesale industry P/E ratio of 16.9 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates McKesson as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, solid stock price performance, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full McKesson Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

If you liked this article you might like

How World's Largest Drug Distributor Is Helping Harvey Victims Treat Snakebites

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Eclipse in the USA: Then and Now

Finding Value in a Pricey Environment

Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal